The group, who will each serve four-year terms, includes:
- Judith Campisi, Ph.D., Professor, Buck Institute for Research on Aging
- Mitchell Kronenberg, Ph.D., President and Chief Scientific Officer, La Jolla Institute for Immunology
- Karen E. Nelson, Ph.D., President, Craig Venter Institute
- Phil Newmark, Ph.D., Investigator, Morgridge Institute for Research
- Bruce Walker, M.D., Director, Ragon Institute of MGH, MIT and Harvard
“Science is constantly evolving, and the needs of scientific programs benefit from neutral, external perspectives,” Texas Biomed President/CEO and Professor Larry Schlesinger, M.D., said. “As we implement our ambitious 10-year vision for change at Texas Biomed, it is imperative we receive support and guidance from some of the brightest minds in biomedical research outside of our own institution, and I am excited about the group that has chosen to participate. The board provides an opportunity not only for us to learn but to share our distinguishing perspective on science with other institutions.”
As advisors, the researchers from diverse fields will provide counsel to Texas Biomed on its strategic direction and the appropriateness of research priorities. They will also give feedback on training programs, finance/business development and organizational structure. As an independent, nonprofit research institute, Texas Biomed has distinct strengths and challenges that benefit from external counsel.
“Diversity is important to ecosystems,” Dr. Walker stressed. “An important part of the scientific ecosystem in addition to academia, biotech and pharma is the independent research institute, a source of bold new ideas and the flexibility to rapidly take them forward.”
“Texas Biomedical Research Institute will significantly advance our effort to improve the health span of its constituents through outstanding scientific and education programs,” Dr. Campisi added. “I am delighted to serve on the advisory board of this outstanding institution.”
The first in-person meeting of Texas Biomed’s new External Scientific Advisory Board is scheduled for spring 2020.
Additionally, Texas Biomed’s Southwest National Primate Research Center (SNPRC) has established its own external board of advisors. These leading scientists and veterinarians are providing strategic advice and counsel in the future development of SNPRC. Members of this committee include:
- Konstantin Kousoulas, Ph.D., Director/Professor, LSU School of Veterinary Medicine
- Afonso C. Silva, Ph.D., Professor, University of Pittsburgh Brain Institute
- Joyce K. Cohen, VMD, DACLAM, Associate Director, Yerkes National Primate Research Center
- Robert Seder, M.D., National Institute of Allergy and Infectious Diseases
- Joanne L. Flynn, Ph.D., Professor, University of Pittsburgh School of Medicine
- Rudolf P. Bohm, Jr., DV, DACLAM, Associate Director, Tulane National Primate Research Center
The SNPRC is supported by grant P51 OD011133 from the Office of Research Infrastructure Programs, National Institutes of Health.
Texas Biomed is one of the world’s leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. The Institute is home to the Southwest National Primate Research Center (SNPRC) and provides broad services in primate research. SNPRC contributes to a national network of National Primate Research Centers (NPRCs) with specialized technologies, capabilities and primate resources, many of which are unique to the SNPRC. The Center also serves investigators around the globe with research and technical procedures for collaborative projects. For more information on Texas Biomed, go to www.TxBiomed.org or for more information on SNPRC, visit www.SNPRC.org.
Original post https://alertarticles.info